At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,385 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cryo Global Registry, a Part of the Medtronic Cardiac Ablation Post-Market Study Platform
In Brief
An observational study for Atrial Fibrillation. Completed, enrolled 5,385 participants across 163 sites in 38 countries.
Detailed Summary
Cryo Global Registry a prospective, global, multi-center, observational Post-Market Registry
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesArgentina, Austria, Belgium, Brunei, Chile, China, Colombia, Czechia, Germany, Greece, Hungary, Iceland, India, Indonesia, Italy, Japan, Kazakhstan, Kuwait, Malaysia, Mexico, Oman, Philippines, Poland, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Switzerland, Taiwan, Thailand, United Arab Emirates, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartMay 2016
Primary CompletionNov 2024
TodayJul 2026
First PostedApr 27, 2016
Enrollment StartMay 2, 2016
Primary CompletionNov 29, 2024
TodayJul 2, 2026
Enrollment to primary: 8.6 yearsPosted 10.2 years ago